Dr. Goran Bajic's research lab focuses on understanding how our immune system responds to vaccines and infections, especially in the context of evolving viruses like SARS-CoV-2. The lab utilizes advanced techniques to study B cells, which play a crucial role in producing antibodies. By analyzing how these immune responses develop at a molecular level, the lab aims to improve vaccine design and enhance our capacity to fight rapidly changing pathogens, including various coronaviruses.

Dr. Stephen M. Rich's lab at the University of Massachusetts Amherst focuses on tackling vector-borne diseases, particularly those transmitted by ticks in New England. The lab collaborates with regional universities and aims to control tick populations and reduce Lyme disease cases through applied research, training public health entomologists, and engaging the community. Their work is critical for public health and involves developing strategies and technologies to better manage and prevent tick bites.

Dr. Stefan Rothenburg's lab focuses on developing innovative strategies to combat viruses that are transmitted by animals and insects. They are working on a project to create recombinant antiviral proteins (called REAVRs) that can sense and inhibit the replication of various viruses. By improving the immune response in mosquitoes, they aim to reduce the risk of zoonotic diseases affecting humans.

Dr. Wei Sun's lab at Albany Medical College focuses on creating innovative vaccines to fight against plague, a serious infectious disease caused by Yersinia pestis. The lab is particularly interested in developing Yersinia outer-membrane vesicle vaccines to offer more effective protection than current options. By studying how these vesicles can stimulate the immune system, they aim to contribute significantly to public health by addressing the threat of plague, especially in cases of drug-resistant strains.

The research lab of Gabriel D Victora at Rockefeller University focuses on understanding how the immune system, particularly B cells, generates antibodies to fight infections and diseases. Their work investigates the mechanisms behind antibody production in the gut, how B cells select specific microbial targets, and how this process contributes to health and disease, such as inflammatory bowel disease and cancer. The lab employs advanced experimental techniques to map the complexities of immune responses, aiming to improve vaccine design and therapeutic strategies.

Dr. Adolfo Garcia-Sastre's lab at the Icahn School of Medicine focuses on studying how viruses, particularly SARS-CoV-2 and other coronaviruses, adapt to human hosts. By utilizing systems biology approaches and advanced modeling techniques, the lab aims to uncover biological networks that influence viral replication and disease severity. Their research seeks to identify potential biomarkers and therapeutic targets that can help in predicting disease outcomes and developing new treatments.

Dr. Peter Sarnow's lab at Stanford University focuses on understanding how certain viruses use circular RNAs to impact infection outcomes. They investigate how these virus-derived circular RNAs, produced during infections by viruses like hepatitis C and SARS-CoV-2, might influence viral behavior and potentially lead to new antiviral strategies. This research is crucial for developing effective treatments and vaccines against viral diseases, particularly in the context of emerging viral variants and diseases.

Dr. Jeffrey R. Johnson's lab focuses on understanding how viruses like HIV-1 and SARS-CoV-2 manipulate human cells during infection. The research aims to uncover the mechanisms by which these viruses degrade host proteins to enhance their replication and to identify potential therapeutic targets for treating viral infections. Through various molecular and genetic techniques, the lab strives to advance our understanding of viral biology and contribute to the development of new antiviral therapies.

Dr. Angus C. Wilson's lab studies how viruses, particularly the herpes simplex virus (HSV-1), manipulate host cell functions to enhance their replication. They explore the ways HSV-1 disrupts the host's genetic processes, particularly focusing on RNA processing and the cellular responses to stress that can trigger virus reactivation. Through their research, they hope to uncover new strategies to develop antiviral therapies against viral infections and understand their impact on the nervous system.

Craig E. Cameron's lab at the University of North Carolina focuses on understanding how certain viruses, particularly coronaviruses and non-polio enteroviruses, replicate their genomes and assemble themselves within host cells. By studying the enzymes involved in these processes, particularly the 2C protein of enteroviruses and the replisome of coronaviruses, the lab aims to discover new antiviral therapies and improve our understanding of viral infections. Their research has significant implications for public health, especially in combating emerging viral threats.

Dr. Marina Caskey's lab at Rockefeller University focuses on understanding and combating viral infections, particularly HIV and hepatitis B virus (HBV). The lab conducts innovative research to investigate how HIV escapes treatments with broadly neutralizing antibodies (bNAbs) and explores new therapeutic strategies for chronic HBV infection. The goal is to improve immune responses and develop effective treatments that can lead to long-term remission of these viral infections.

Dr. Michael Gale's lab at the University of Minnesota focuses on understanding how the immune system responds to viral infections, specifically West Nile virus and the use of a unique vaccine strategy for HIV prevention. The research explores both the mechanisms that allow viruses to invade the central nervous system and how vaccines can be designed to elicit effective immune responses. By using innovative models and advanced sequencing technologies, the lab aims to uncover critical information that could lead to better treatments and vaccines against these serious viral threats.

Dr. Ana Fernandez-Sesma's lab focuses on understanding the human immune response to various viral infections and vaccinations, specifically SARS-CoV-2, seasonal influenza, and dengue viruses. The lab conducts comprehensive studies using advanced techniques to analyze immune system responses before and after vaccination, utilizing data from different human cohorts. By leveraging cutting-edge genomics and immunological profiling methods, the lab aims to generate valuable insights into vaccine effectiveness and immune memory.

Dr. Richard E. Lloyd's lab at Baylor College of Medicine focuses on the relationship between viral infections and the immune responses that can lead to autoimmune diseases like Type 1 Diabetes in children. The research examines how prolonged infections with enteroviruses might trigger immune changes associated with this disease. Through this work, the lab aims to provide insights that could lead to preventive strategies for Type 1 Diabetes.

Dr. Dohun Pyeon's lab focuses on understanding how certain viruses, specifically human papillomaviruses (HPV), contribute to the progression of head and neck cancers. They aim to uncover the mechanisms that allow these cancers to evade the immune system, particularly by studying a specific protein that degrades immune receptors, which helps tumor cells escape detection. By targeting these pathways, the lab seeks to develop new immunotherapies that could improve treatment outcomes for patients with HPV-related head and neck cancers.

Dr. Benhur Lee's lab is focused on researching henipaviruses and pararubulaviruses, which are serious threats to public health due to their high fatality rates and potential for causing pandemics. The lab develops antibodies that can neutralize these viruses and studies how they infect human cells. The goal is to provide effective treatments and preventive strategies against these dangerous viruses, enhancing global health security.

Rachel Fearns' lab focuses on understanding how viruses, particularly the human parainfluenza virus, replicate their genomes and produce RNA. They investigate the structural and molecular mechanics underlying viral transcription and replication, especially how these processes are regulated. The goal is to better understand these mechanisms to aid in the development of antiviral therapies.

Jacob Yount's lab focuses on understanding how the SARS-CoV-2 virus causes severe damage to the lungs and heart, particularly in individuals with certain immune deficiencies. By studying specific immune responses and inflammatory pathways, they aim to find new ways to prevent and treat COVID-19 complications. Their research involves looking at how different proteins and immune cells contribute to disease severity, which could lead to tailored therapies for vulnerable populations.

Dr. Sean Pj Whelan's lab at Washington University focuses on understanding how SARS-CoV-2, the virus responsible for COVID-19, enters cells and how to block this process to develop effective therapeutics. The lab employs advanced imaging techniques and genetic screening to map the viral entry pathways and identify host proteins that the virus hijacks during infection. Their research aims to uncover new therapeutic targets while also evaluating the effectiveness of current clinical interventions against the virus.

Dr. Derek Walsh's lab at Northwestern University studies how certain viruses manipulate host cells during infection. They focus on the unusual behavior of Cytomegalovirus (HCMV) and poxviruses, investigating how these viruses impact cell structures and functions to enhance their replication and spread. The research combines advanced imaging techniques with molecular biology to unravel the complex interactions between viruses and host cells, paving the way for potential therapeutic developments.